| Variable (ALL) N=152 | Frequency | Reference Ranges | ||
|---|---|---|---|---|
| Below normal | Elevated | Normal | - | |
| Demographics (N=152) | n(%) | n(%) | n(%) | - |
| BMI (kg/m2) | 10 (7) | 56 (37) | 86 (56) | 18.6-24.9 |
| SBP (mmHg) | N/A | 48 (32) | 104 (68) | ≥130 |
| DBP (mmHg)l2 | N/A | 47 (31) | 105 (69) | ≥85 |
| ART History, N=152 | - | Naïve | Experienced | - |
| Frequency/n(%) | N/A | 28 (18) | 124 (82) | N/A |
| Clinical data (N=152) | n(%) | n(%) | n(%) | - |
| Nadir CD4 (cells/mm3) | 146 (96) | N/A | 6 (4) | >500 |
| CD4 at time of study (cells/mm3) | 49 (32) | N/A | 103 (68) | >500 |
| Viral load (counts per mL) | N/A | 14 (9%) | 138 (91) | <1000 |
| Lipids (N=152) | n(%) | n(%) | n(%) | - |
| LDL-C (mmol/L) | N/A | 48 (32) | 104 (68) | >2.59 |
| TC (mmol/L) | N/A | 8 (6) | 144 (94) | >5.17 |
| HDL-C (mmol/L) | 91 (60) | N/A | 61 (40) | <1.03Males <1.29 Females |
| TC/HDL-C ratio | N/A | 38 (25) | 114 (75) | >4.5 |
| Inflammatory Markers | n(%) | n(%) | n(%) | - |
| IL10 (pg/ml) N=152 | N/A | 60 (39) | 92 (61) | 0.4–2.0 [23, 25, 26] |
| TNFα (pg/ml) N=152 | N/A | 6 (4) | 146 (96) | 0.0–32.5 [25, 26] |
| hsCRP (mg/dL) N*=65 | N/A | 58 (38) | 94 (62) | 0-3 |
| Variable (FEMALES ONLY) N=113 | Frequency | Reference Ranges | ||
| - | Below normal | Elevated | Normal | - |
| Demographics (N=113) | n(%) | n(%) | n(%) | - |
| BMI (kg/m2) | 3 (3) | 49 (43) | 61 (54) | 18.6-24.9 |
| SBP (mmHg) | N/A | 34 (30) | 79(70) | ≥130 |
| DBP (mmHg) | N/A | 34 (30) | 79 (70) | ≥85 |
| ART History (N=113) | - | Naïve | Experienced | - |
| Frequency/n(%) | N/A | 19 (17) | 94 (83) | - |
| Clinical Data (N=113) | n(%) | n(%) | n(%) | - |
| Nadir CD4 (cells/mm3) | 90 (80) | N/A | 23 (20) | >500 |
| CD4 at time of study (cells/mm3) | 23 (20) | N/A | 90 (80) | >500 |
| Viral load (counts per mL) | N/A | 9 (8) | 104 (92) | <1000 |
| Lipids (N=113) | n(%) | n(%) | n(%) | - |
| LDL-C (mmol/L) | N/A | 47 (42) | 66 (58) | >2.59 |
| TC (mmol/L) | N/A | 7 (6) | 106 (94) | >5.17 |
| HDL-C (mmol/L) | 72 (64) | N/A | 41 (36) | <1.03Males <1.29 Females |
| TC/HDL-C ratio | N/A | 24 (21) | 89 (79) | >4.5 |
| Inflammatory Markers | n(%) | n(%) | n(%) | - |
| IL10 (pg/ml) [N=113] | N/A | 47(42) | 66 (58) | 0.4–2.0 [23, 25, 26] |
| TNFα (pg/ml) [N=113] | N/A | 6 (5) | 107 (95) | 0.0–32.5 [25, 26] |
| hsCRP (mg/dL) [N*=43] | N/A | 15 (35) | 28 (65) | 0-3 |